Liability Risk and Insurance
AAJ calls for change to FDA rule on drug labelling
The American Association for Justice (AAJ) has demanded that the US Food and Drug Administration (FDA) withdraw a proposed
rule that it says would allow drug companies to claim immunity for failing to warn patients of potential drug hazards.